NCT02277730

Brief Summary

Hypotension occurs commonly during spinal anaesthesia for caesarean section with maternal and fetal adverse effects. The investigators developed a double-vasopressor automated system incorporating continuous non-invasive haemodynamic monitoring using NexfinTM with a two-step algorithm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
252

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started May 2013

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

October 26, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 29, 2014

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

March 8, 2018

Status Verified

August 1, 2017

Enrollment Period

4.5 years

First QC Date

October 26, 2014

Last Update Submit

March 7, 2018

Conditions

Keywords

Hypotension

Outcome Measures

Primary Outcomes (1)

  • Hypotension

    Systolic blood pressure less than 80% of baseline systolic blood pressure

    1 day

Secondary Outcomes (2)

  • Hypertension

    1 day

  • Nausea and vomiting

    1 day

Study Arms (2)

vasopressor delivery automated system

EXPERIMENTAL

vasopressor delivery automated system administering phenylephrine and ephedrine using a 2 step algorithm vasopressor delivery technique

Device: vasopressor delivery automated systemDrug: phenylephrineDrug: ephedrine

manual vasopressor delivery

ACTIVE COMPARATOR

manual bolus delivering phenylephrine and ephedrine using a 2 step algorithm vasopressor delivery technique

Drug: phenylephrineDrug: ephedrineDevice: manual vasopressor delivery

Interventions

vasopressor delivery using phenylephrine and ephedrine

Also known as: vasopressor delivery technique
vasopressor delivery automated system
Also known as: vasopressor
manual vasopressor deliveryvasopressor delivery automated system
Also known as: vasopressor
manual vasopressor deliveryvasopressor delivery automated system
manual vasopressor delivery

Eligibility Criteria

Age21 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age 21-45 years old,
  • weight 40-90 kg,
  • height 145-170 cm

You may not qualify if:

  • contraindications to spinal anaesthesia,
  • allergy to drugs used in the study, and
  • those with uncontrolled medical conditions such as hypertension, diabetes mellitus, and cardiovascular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KK Women's and Children's Hospital

Singapore, 229899, Singapore

Location

Related Publications (2)

  • Du EW, Tan HS, Tan CW, Sultana R, Sng BL. Heart rate variability and haemodynamic factors associated with hypotension during spinal anaesthesia for caesarean delivery: A case-control study. Eur J Anaesthesiol. 2022 Mar 1;39(3):219-226. doi: 10.1097/EJA.0000000000001551.

  • Sng BL, Du W, Lee MX, Ithnin F, Mathur D, Leong WL, Sultana R, Han NR, Sia ATH. Comparison of double intravenous vasopressor automated system using nexfin versus manual vasopressor bolus administration for maintenance of haemodynamic stability during spinal anaesthesia for caesarean delivery: A randomised double-blind controlled trial. Eur J Anaesthesiol. 2018 May;35(5):390-397. doi: 10.1097/EJA.0000000000000779.

MeSH Terms

Conditions

Hypotension

Interventions

PhenylephrineVasoconstrictor AgentsEphedrine

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

EthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAminesCardiovascular AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and UsesPropanolaminesPropanolsPhenethylaminesEthylamines

Study Officials

  • Ban L Sng, FANZCA

    KK Women's and Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2014

First Posted

October 29, 2014

Study Start

May 1, 2013

Primary Completion

November 1, 2017

Study Completion

December 1, 2017

Last Updated

March 8, 2018

Record last verified: 2017-08

Locations